全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

肺炎球菌社区获得性肺炎相关心血管并发症的研究进展
Research Advances in Pneumococcal Community-Acquired Pneumonia-Related Cardiovascular Complications

DOI: 10.12677/ACM.2022.127877, PP. 6083-6089

Keywords: 肺炎球菌,社区获得性肺炎,溶血素,心血管并发症
Pneumococcus
, Community-Acquired Pneumonia, Hemolysin, Cardiovascular Complications

Full-Text   Cite this paper   Add to My Lib

Abstract:

社区获得性肺炎的发病率(community-acquired pneumonia, CAP)和死亡率居高不下,是全球性健康问题。有相关文献报道CAP患者患心血管事件的风险逐年升高。其中包括心律失常的发生、新发的心力衰竭/急性心肌梗死或心力衰竭/心肌梗死恶化。有研究确定了肺炎链球菌导致心血管事件(cardiovascular events, CVE)的一些机制,这些心血管事件的发生与患者的临床预后及长期死亡率有着密切关系,本研究拟就肺炎球菌CAP患者发生心血管事件的相关进展及治疗进行综述。
The incidence and mortality of community-acquired pneumonia (CAP) are high, which is a global health problem. It has been reported that the risk of cardiovascular events in patients with CAP in-creases year by year. These include the occurrence of arrhythmias, new heart failure/acute myo-cardial infarction or heart failure/myocardial infarction deterioration. Some studies have confirmed some mechanisms of cardiovascular events caused by Streptococcus pneumoniae. The occurrence of these cardiovascular events is closely related to the clinical prognosis and long-term mortality. This study is to review the progress and treatment of cardiovascular events in patients with pneumo-coccal CAP.

References

[1]  Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. (2015) Community-Acquired Pneu-monia Requiring Hospitalization among US Adults. The New England Journal of Medicine, 373, 415-427.
https://doi.org/10.1056/NEJMoa1500245
[2]  Jiang, S., Liu, T., Hu, Y., Li, R., Di, X., Jin, X., et al. (2019) Effi-cacy and Safety of Glucocorticoids in the Treatment of Severe Community-Acquired Pneumonia: A Meta-Analysis. Medicine, 98, Article ID: e16239.
https://doi.org/10.1097/MD.0000000000016239
[3]  Violi, F., Cangemi, R., Falcone, M., Taliani, G., Pieralli, F., Vannucchi, V., et al. (2017) Cardiovascular Complications and Short-Term Mortality Risk in Community-Acquired Pneumonia. Clinical Infectious Diseases, 64, 1486-1493.
https://doi.org/10.1093/cid/cix164
[4]  Feldman, C. and Anderson, R. (2016) Prevalence, Pathogenesis, Therapy, and Prevention of Cardiovascular Events in Patients with Community-Acquired Pneumonia. Pneumonia, 8, Article No. 11.
https://doi.org/10.1186/s41479-016-0011-0
[5]  Restrepo, M.I., Reyes, L.F. and Anzueto, A. (2016) Complication of Community-Acquired Pneumonia (Including Cardiac Complications). Seminars in Respiratory and Critical Care Medicine, 37, 897-904.
https://doi.org/10.1055/s-0036-1593754
[6]  Borchers, A. and Pieler, T. (2010) Programming Pluripotent Precur-sor Cells Derived from Xenopus Embryos to Generate Specific Tissues and Organs. Genes, 1, 413-426.
https://doi.org/10.3390/genes1030413
[7]  Cilli, A., Cakin, O., Aksoy, E., et al. (2018) Acute Cardiac Events in Severe Community-Acquired Pneumonia: A Multicenter Study. The Clinical Respiratory Journal, 12, 2212-2219.
https://doi.org/10.1111/crj.12791
[8]  Musher, D.M., Rueda, A.M., Kaka, A.S. and Mapara, S.M. (2007) The Association between Pneumococcal Pneumonia and Acute Cardiac Events. Clinical Infectious Diseases, 45, 158-165.
https://doi.org/10.1086/518849
[9]  Eurich, D.T., Marrie, T.J., Minhas-Sandhu, J.K. and Majumdar, S.R. (2017) Risk of Heart Failure after Community Acquired Pneumonia: Prospective Controlled Study with 10 Years of Follow-Up. BMJ, 356, Article No. j413.
https://doi.org/10.1136/bmj.j413
[10]  Marrie, T.J., Tyrrell, G.J., Majumdar, S.R. and Eurich, D.T. (2017) Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments. Canadian Respira-tory Journal, 2017, Article ID: 2397429.
https://doi.org/10.1155/2017/2397429
[11]  Brown, A.O., Mann, B., Gao, G., Hankins, J.S., Humann, J., Giardina, J., et al. (2014) Streptococcus Pneumoniae Translocates Into the Myocardium and Forms Unique Microlesions That Disrupt Cardiac Function. PLOS Pathogens, 10, Article ID: e1004383.
https://doi.org/10.1371/journal.ppat.1004383
[12]  Brown, A.O., Millett, E.R., Quint, J.K. and Orihuela, C.J. (2015) Cardiotoxicity during Invasive Pneumococcal Disease. American Journal of Respiratory and Critical Care Medi-cine, 191, 739-745.
https://doi.org/10.1164/rccm.201411-1951PP
[13]  Nel, J.G., Durandt, C., Theron, A.J., Tintinger, G.R., Pool, R., Richards, G.A., et al. (2017) Pneumolysin Mediates Heterotypic Aggregation of Neutrophils and Platelets in Vitro. The Journal of Infection, 74, 599-608.
https://doi.org/10.1016/j.jinf.2017.02.010
[14]  Cangemi, R., Casciaro, M., Rossi, E., Calvieri, C., Bucci, T., Cala-brese, C.M., et al. (2014) Platelet Activation Is Associated with Myocardial Infarction in Patients with Pneumonia. Jour-nal of the American College of Cardiology, 64, 1917-1925.
https://doi.org/10.1016/j.jacc.2014.07.985
[15]  Kou-penova, M., Clancy, L., Corkrey, H.A. and Freedman, J.E. (2018) Circulating Platelets as Mediators of Immunity, In-flammation, and Thrombosis. Circulation Research, 122, 337-351.
https://doi.org/10.1161/CIRCRESAHA.117.310795
[16]  王静, 荣柏洋, 牛慧, 朱文凯, 赵志鹏, 谢建军, 等. 肺炎球菌溶血素在社区获得性肺炎心肌损伤中的作用[J]. 临床肺科杂志, 2020, 25(3): 452-4.
[17]  Nel, J.G., The-ron, A.J., Durandt, C., Tintinger, G.R., Pool, R., Mitchell, T.J., et al. (2016) Pneumolysin Activates Neutrophil Extracel-lular Trap Formation. Clinical and Experimental Immunology, 184, 358-367.
https://doi.org/10.1111/cei.12766
[18]  Stakos, D.A., Kambas, K., Konstantinidis, T., Mitroulis, I., Apostolidou, E., Arelaki, S., et al. (2015) Expression of Functional Tissue Factor by Neutrophil Extracellular Traps in Culprit Artery of Acute Myocardial Infarction. European Heart Journal, 36, 1405-1414.
https://doi.org/10.1093/eurheartj/ehv007
[19]  Oz, F., Gul, S., Kaya, M.G., Yazici, M., Bulut, I., Elitok, A., et al. (2013) Does Aspirin Use Prevent Acute Coronary Syndrome in Patients with Pneumonia: Multicenter Prospective Ran-domized Trial. Coronary Artery Disease, 24, 231-237.
https://doi.org/10.1097/MCA.0b013e32835d7610
[20]  Batais, M.A., Khan, A.R. and Bin Abdulhak, A.A. (2017) The Use of Statins and Risk of Community-Acquired Pneumonia. Current Infectious Disease Reports, 19, 26.
https://doi.org/10.1007/s11908-017-0581-x
[21]  吴泽萍, 郭中敏, 陆家海. 他汀类药物对社区获得性肺炎影响的研究进展[J]. 热带医学杂志, 2019, 19(1): 120-124.
[22]  Brassard, P., Wu, J.W., Ernst, P., Dell’Aniello, S., Smiechowski, B. and Suissa, S. (2017) The Effect of Statins on Influenza-Like Illness Morbidity and Mortality. Phar-macoepidemiology and Drug Safety, 26, 63-70.
https://doi.org/10.1002/pds.4112
[23]  杨志春, 朱鸿丹, 赵云静, 尹粉英, 范敏娟. β-内酰胺类药物联合大环内酯类药物治疗成人社区获得性肺炎的研究进展[J]. 实用临床医药杂志, 2022, 26(5): 139-143.
[24]  Garin, N., Genné, D., Carballo, S., Chuard, C., Eich, G., Hugli, O., et al. (2014) β-Lactam Monotherapy vs β-Lactam- Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. JAMA Internal Medicine, 174, 1894-901.
https://doi.org/10.1001/jamainternmed.2014.4887
[25]  Nickler, M., Ot-tiger, M., Steuer, C., Kutz, A., Christ-Crain, M., Zimmerli, W., et al. (2017) Time-Dependent Association of Glucocorti-coids with Adverse Outcome in Community-Acquired Pneumonia: A 6-Year Prospective Cohort Study. Critical Care, 21, Article No. 72.
https://doi.org/10.1186/s13054-017-1656-7
[26]  孟贝贝, 刘学花. 糖皮质激素在重症肺炎治疗中的应用进展[J]. 国际呼吸杂志, 2020, 40(21): 1664-1668.
[27]  张艳艳, 崔曼曼, 唐超. 糖皮质激素辅助治疗社区获得性肺炎最新研究进展[J]. 临床肺科杂志, 2020, 25(3): 466-8+76.
[28]  Ceccato, A., Cilloniz, C., Ranzani, O.T., Menendez, R., Agusti, C., Gabarrus, A., et al. (2017) Treatment with Macrolides and Glucocorticosteroids in Se-vere Community-Acquired Pneumonia: A Post-Hoc Exploratory Analysis of a Randomized Controlled Trial. PLOS ONE, 12, Article ID: e0178022.
https://doi.org/10.1371/journal.pone.0178022
[29]  Laterre, P.F., Colin, G., Dequin, P.F., Dugernier, T., Boulain, T., Azeredo da Silveira, S., Lajaunias, F., et al. (2019) Cal02, A Novel Antitoxin Liposomal Agent, in Severe Pneumococcal Pneumonia: A First-in-Human, Double-Blind, Placebo-Controlled, Random-ised Trial. The Lancet Infectious Diseases, 19, 620-630.
https://doi.org/10.1016/S1473-3099(18)30805-3
[30]  刘宗华. 以溶血素为抗原的新型肺炎球菌疫苗的研究进展[J]. 中国生物制品学杂志, 2021, 34(2): 220-224.
[31]  Shepard, H.M., Phillips, G.L., Thanos, C.D. and Feldmann, M. (2017) Developments in Therapy with Monoclonal Antibodies and Related Proteins. Clinical Medicine, 17, 220-232.
https://doi.org/10.7861/clinmedicine.17-3-220
[32]  王小衡. 儿童肺炎球菌性肺炎特点及防治[J]. 医师在线, 2017, 7(33): 13.
[33]  Ren, S., Newby, D., Li, S.C., Walkom, E., Miller, P., Hure, A., et al. (2015) Effect of the Adult Pneumococcal Polysaccharide Vaccine on Cardiovascular Disease: A Systematic Review and Meta-Analysis. Open Heart, 2, e000247.
https://doi.org/10.1136/openhrt-2015-000247

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133